PIERRE BLANCHARD
Allopathic & Osteopathic Physicians|Internal Medicine SHREVEPORT, LA NPI 1104889237
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine LA PFIZER INC. All categories
General Payments — all program years on this page
$4,389.62
- Category: General Payments
- Program years: PY2018–2024
- Record count: 319
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $854.25 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $854.25 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $150.91 | 11 |
| Phathom Pharmaceuticals, Inc. | $85.46 | 5 |
| Acerta Pharma LLC | $83.30 | 5 |
| Lilly USA, LLC | $78.67 | 5 |
| GlaxoSmithKline, LLC. | $75.55 | 4 |
| DEXCOM, INC. | $66.13 | 4 |
| Amgen Inc. | $48.01 | 3 |
| Otsuka America Pharmaceutical, Inc. | $35.40 | 2 |
| Xeris Pharmaceuticals, Inc. | $30.82 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.27 | 1 |
| Novo Nordisk AS | $28.99 | 2 |
| Mylan Specialty L.P. | $22.35 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.75 | 1 |
| Lundbeck LLC | $17.89 | 1 |
| ABIOMED | $17.71 | 1 |
| Ultragenyx Pharmaceutical Inc. | $17.61 | 1 |
| Astellas Pharma US Inc | $17.15 | 1 |
| Sumitomo Pharma America, Inc. | $16.88 | 1 |
| Mallinckrodt Hospital Products Inc. | $13.40 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.